Merck KGaA (ETR:MRK) subsidiary MilliporeSigma has opened its second facility in Carlsbad, California, near San Diego. The new $110 million, 140,000-ft² facility more than doubles its production capacity supporting viral gene therapy. The company now has two facilities dedicated to serving customers focused on cell and gene therapy. The facilities can support suspension production of…